Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01275 (
glucagon
)
26,492
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Glutamate has been suggested to play an important role in the release of insulin and
glucagon
from pancreatic cells via exocytosis. Vesicular glutamate transporter is a rate-limiting step for glutamate release and is involved in the glutamate-evoked exocytosis. Two vesicular glutamate transporters (VGLUT1 and -2) have recently been cloned from the brain. In this report, we first functionally characterized vesicular glutamate transporter in cultured pancreatic alpha- and beta-cells, and then detected mRNA expression of VGLUT1 and -2 in these cells. We also investigated the effect of high or low level of glucose on vesicular glutamate transport in cultured pancreas cells. Our results suggest that both alpha- and beta-cells contain functional vesicular glutamate transporter. The transport characteristics are similar to the cloned neuronal VGLUT1 and -2 in regard to ATP dependence, substrate specificity, kinetics, and chloride dependence.
VGLUT2
mRNA is expressed in both alpha- and beta-cells, whereas VGLUT1 is only expressed in beta-cells. High (12.8 mM) and low (2.8 mM) concentrations of glucose increased vesicular glutamate transport in beta- and alpha-cells, respectively.
VGLUT2
mRNA was significantly increased in beta- and alpha-cells by high and low glucose concentration, respectively. This increase in
VGLUT2
mRNA was suppressed by actinomycin D. We conclude that both alpha- and beta-cells possess functional vesicular glutamate transporters regulated by alteration in glucose concentration, partly via the transcriptional mechanism.
...
PMID:Characterization of vesicular glutamate transporter in pancreatic alpha - and beta -cells and its regulation by glucose. 1244 14
The wide-ranging expression of glutamate receptors in peripheral tissues suggests an unexpectedly wider role(s) of l-glutamate as an intercellular signaling molecule. However, the peripheral glutamatergic system is poorly understood, partly because the sites of l-glutamate signal appearance are less well characterized. Vesicular glutamate transporters (VGLUTs) are potential probes for the sites of vesicular storage and subsequent secretion of l-glutamate. In this study we raised specific polyclonal antibodies against two VGLUT isoforms, VGLUT1 and
VGLUT2
, and investigated their localization in peripheral tissues of rat. We detected the expression of either VGLUT1 or
VGLUT2
, or both, in pancreas, stomach, intestine, and testis. In pancreas, VGLUT1 and
VGLUT2
are present in pancreatic polypeptide-containing secretory granules in F-cells in the islets of Langerhans. In stomach,
VGLUT2
is abundant in the antrum and pylorus and is present in a subset of pancreatic polypeptide-containing cells. In intestine,
VGLUT2
is abundant in the ileum and is co-localized with
glucagon
-like immunoreactive peptide and polypeptide YY (PYY). In testis,
VGLUT2
is expressed and localized in the outer acrosomal membrane of spermatids, where KA1 and GluR5, kainate receptor subunits, are almost always localized. Taken together, these results strongly suggest the occurrence of a peripheral glutamatergic system in the gastroenteropancreatic system and testis.
...
PMID:Expression and localization of vesicular glutamate transporters in pancreatic islets, upper gastrointestinal tract, and testis. 1450 Jul 5
Vesicular glutamate transporter (VGLUT) is responsible for the vesicular storage of l-glutamate, and plays an essential role in glutamate-mediated intercellular signal transmission in the CNS and in some neuroendocrine cells. Intestinal L cells are the glucose-responsive neuroendocrine cells responsible for the secretion of
glucagon-like peptide 1
(
GLP-1
). We have shown that intestinal L cells express
VGLUT2
, a VGLUT isoform, which suggests that L cells secrete L-glutamate. In the present study, we investigated this possibility using GLUTag mouse clonal L cells. RT-PCR and northern blot analyses revealed expression of the VGLUT1 and
VGLUT2
genes, but not of the VGLUT3 gene. Western blot analysis revealed immunological counterparts for
VGLUT2
, whereas an immunological counterpart of VGLUT1 was not detected. Indirect immunofluorescence microscopy revealed a punctate distribution of
VGLUT2
immunoreactivity throughout the cells, which co-localized with
GLP-1
. Double-labeling immunoelectronmicroscopy confirmed the association of
VGLUT2
with
GLP-1
-containing secretory granules. The membrane fraction exhibited ATP-dependent L-glutamate uptake, which was sensitive to bafilomycin A1 (a vacuolar proton ATPase inhibitor) and Evans blue (a VGLUT inhibitor) but insensitive to D,L-aspartate. Upon depolarization with KCl, GLUTag cells secreted appreciable amounts of L-glutamate and
GLP-1
. D-Glucose and methyl-alpha-D-glucopyranoside, stimulators of exocytosis of
GLP-1
, also triggered the secretion of L-glutamate. The L-glutamate secretion was partially dependent on Ca2+ and sensitive to bafilomycin A1. These results demonstrated that GLUTag cells stored L-glutamate in secretory granules and secreted it with
GLP-1
by exocytosis. As GLUTag cells and intestinal L cells express kainate receptors and plasma membrane glutamate transporters, these results support the concept of L-glutamate-mediated intercellular signaling in the vicinity of intestinal L cells.
...
PMID:Vesicular storage and secretion of L-glutamate from glucagon-like peptide 1-secreting clonal intestinal L cells. 1633 30
The importance of neuropeptides in the hypothalamus has been experimentally established. Due to difficulties in assessing function in vivo, the roles of the fast-acting neurotransmitters glutamate and GABA are largely unknown. Synaptic vesicular transporters (VGLUTs for glutamate and VGAT for GABA) are required for vesicular uptake and, consequently, synaptic release of neurotransmitters. Ventromedial hypothalamic (VMH) neurons are predominantly glutamatergic and express
VGLUT2
. To evaluate the role of glutamate release from VMH neurons, we generated mice lacking
VGLUT2
selectively in SF1 neurons (a major subset of VMH neurons). These mice have hypoglycemia during fasting secondary to impaired fasting-induced increases in the glucose-raising pancreatic hormone
glucagon
and impaired induction in liver of mRNAs encoding PGC-1alpha and the gluconeogenic enzymes PEPCK and G6Pase. Similarly, these mice have defective counterregulatory responses to insulin-induced hypoglycemia and 2-deoxyglucose (an antimetabolite). Thus, glutamate release from VMH neurons is an important component of the neurocircuitry that functions to prevent hypoglycemia.
...
PMID:Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. 1748 40
The expression of a vesicular glutamate transporter (VGLUT) suffices to assign a glutamatergic phenotype to neurons and other secretory cells. For example, intestinal L cells express
VGLUT2
and secrete glutamate along with
glucagon-like peptide 1
(
GLP1
). We hypothesized that
GLP1
-positive neurons within the caudal (visceral) nucleus of the solitary tract (cNST) also are glutamatergic. To test this, the axonal projections of
GLP1
and other neurons within the cNST were labeled in rats via iontophoretic delivery of anterograde tracer. Dual immunofluorescence and confocal microscopy was used to visualize tracer-,
GLP1
-, and
VGLUT2
-positive fibers within brainstem, hypothalamic, and limbic forebrain nuclei that receive input from the cNST. Electron microscopy was used to confirm
GLP1
and
VGLUT2
immunolabeling within the same axon varicosities, and fluorescent in situ hybridization was used to examine
VGLUT2
mRNA expression by
GLP1
-positive neurons. Most anterograde tracer-labeled fibers displayed
VGLUT2
-positive varicosities, providing new evidence that ascending axonal projections from the cNST are primarily glutamatergic. Virtually all
GLP1
-positive varicosities also were
VGLUT2
-positive. Electron microscopy confirmed the colocalization of
GLP1
and
VGLUT2
immunolabeling in axon terminals that formed asymmetric (excitatory-type) synapses with unlabeled dendrites in the hypothalamus. Finally, in situ hybridization confirmed that
GLP1
-positive cNST neurons express
VGLUT2
mRNA. Thus, hindbrain
GLP1
neurons in rats are equipped to store glutamate in synaptic vesicles, and likely co-release both glutamate and
GLP1
from axon varicosities and terminals in the hypothalamus and other brain regions.
...
PMID:Glutamatergic phenotype of glucagon-like peptide 1 neurons in the caudal nucleus of the solitary tract in rats. 2501 14